Skip to content

Based on my review of the GO-CAM model (gomodel:6246724f00001700) and the GO-CAM guidelines, here's my evaluation:

GO-CAM Review: Hyaluronan catabolic process (Mouse) gomodel:6246724f00001700

Overall Assessment

This model represents the hyaluronan catabolic process in mice, showing the molecular activities involved in hyaluronan degradation from receptor-mediated endocytosis through lysosomal degradation. The model appears to be well-constructed and evidence-based, with appropriate use of causal relationships between activities.

Strengths

  1. Comprehensive pathway representation: The model effectively captures the entire process from receptor binding of hyaluronan at the cell surface through transport into lysosomes and subsequent degradation.

  2. Well-evidenced annotations: Each activity is supported by appropriate evidence codes and literature references, using a combination of direct assay evidence (ECO:0000314), mutant phenotype evidence (ECO:0000315), and sequence orthology evidence (ECO:0000266).

  3. Appropriate cellular localization: The model correctly represents the spatial organization of the pathway, with hyaluronan receptors in membrane rafts (GO:0045121) and degradative enzymes in lysosomes (GO:0005764).

  4. Logical causal flow: The causal relationships (RO:0002413 "provides input for" and RO:0002629 "directly positively regulates") are used appropriately to connect activities in a biologically meaningful sequence.

Minor Issues and Suggestions

  1. Missing annotation: The activity gomodel:6246724f00001700/6246724f00001716 (Stab2-enabled receptor activity) is annotated as part of "receptor-mediated endocytosis" (GO:0006898) rather than the overall "hyaluronan catabolic process" (GO:0030214) like most other activities. Consider whether this is intentional or if it should be updated for consistency.

  2. Incomplete cellular component annotations: Some activities, particularly those related to receptor-mediated endocytosis (e.g., gomodel:6246724f00001700/6246724f00001707 for Hmmr), lack "occurs_in" evidence even though they are annotated to occur in membrane rafts (GO:0045121). Adding supporting evidence would strengthen these annotations.

  3. Automated predicate change note: There's a comment noting "Automated change 2023-03-16: RO:0002213 replaced by RO:0002629." This is appropriate as it reflects the updated ontology term usage for direct positive regulation.

Biological Content Assessment

The biological content appears accurate and supported by the cited literature. The model shows:

  1. Four receptors (CD44, HMMR, LYVE1, STAB2) mediating hyaluronan endocytosis
  2. Sodium/proton exchangers (SLC9A1, CHP1) regulating HYAL2 activity
  3. Sequential degradation of hyaluronan by:
  4. HYAL2 (initial degradation)
  5. HYAL1 (further degradation in lysosomes)
  6. GUSB (beta-glucuronidase activity)
  7. HEXA/HEXB (beta-N-acetylhexosaminidase activity)
  8. Appropriate transport mechanisms (SLC17A5 for glucuronate transport)

Recommendations

  1. Consider adding references to some of the causal relationships that lack evidence annotations (many of the RO:0002413 "provides input for" relationships).

  2. Review the part_of relationship for Stab2 (MGI:MGI:2178743) to determine if it should also be part of GO:0030214 rather than only GO:0006898.

  3. Consider adding evidence for the "occurs_in" relationships that are currently lacking evidence codes, particularly for the receptor activities in membrane rafts.

Overall, this is a well-constructed GO-CAM model that effectively represents the hyaluronan catabolic process in mice with strong evidence support and appropriate causal relationships between activities.